Concepedia

Author

Francis Witz

Centre Hospitalier Régional et Universitaire de Nancy

Also Known As

F Witz, F. Huguet, F. Witz, Francis Witz, J Diebold, Witz, Francis

110

Publications

3.5K

Citations

25

H-Index

35

Concepts

All Affiliations

Centre Hospitalier Régional et Universitaire de NancyHôpital Saint-LouisCentre Hospitalier Universitaire d'AngersHôpital PurpanHôpital Cardiologique du Haut-Lévêque
FW

About

Francis Witz is an author at Centre Hospitalier Régional et Universitaire de Nancy specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

823

2

Health Sciences

5

5

307

3

Blood Transplantation

3

3

298

4

Cellular Therapies

1

1

48

5

Epidemiology

1

1

130

Francis Witz

×

37

Publications

3.3K

Citations

25

H-Index

YearCitations

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet‐Rigal,

Blood

2006

343

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

Carole Soussain, Khê Hoang‐Xuan, Luc Taillandier,

Journal of Clinical Oncology

2008

325

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Jean‐Luc Harousseau, Jean‐Yves Cahn, B. Pignon,

PubMed

1997

317

Treatment of Adenovirus Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Pierre Bordigoni, Anne‐Sophie Carret, Véronique Venard,

Clinical Infectious Diseases

2001

262

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study

Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir,

Blood

2008

237

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Francis Witz, Alain Sadoun, M. C. Perrin,

PubMed

1998

147

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

L. Sutton, C Chastang, Patricia Ribaud,

Blood

1996

143

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients

Jérôme Tamburini, Caroline Elie, Valérie Bardet,

Blood

2007

142

Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup

Thomas Prébet, Nicolas Boissel, S. Reutenauer,

Journal of Clinical Oncology

2009

133

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)

Gèrard Socié, J Cahn, Jos Carmelo,

British Journal of Haematology

1997

130

Page 1